Amedisys (AMED) Tops Q1 EPS by 2c; Guides
More News related to AMED
- Amedisys (AMED) Releases Review Report from Marwood Group Advisory
- Amedisys Releases Report from Marwood Group Advisory
- Amedisys to Present at the Oppenheimer 20th Annual Healthcare Conference
- Stifel Nicolaus Upgrades Amedisys (AMED) to Buy
- Amedisys (AMED) options active after reaffirming FY2009 guidance
More News related to Earnings
- After Month's Of Gains, Gold Gives A Little Back Today (GDX, GLD, DGL, More)
- Office Supplies Cos. Up On Jobs Report: OMX, SPLS, ODP
- Synovus Financial (SNV) Running Up on FBR Upgrade
- Staffing Service Stocks Higher As Job Creation Now In Sight: MAN, MWW, RHI, KELYA, TBI, SFN, ASGN
- Novartis for Alcon (ACL)? Novartis Says "No" But Market Says "Yes"
Amedisys Inc. (Nasdaq: AMED) reports Q1 EPS of $0.99, 2 cents better than the analyst estimate of $0.97. Revenue for the quarter was $341.8 million, versus the consensus of $345.5 million.
Amedisys sees FY09 EPS of $4.10-$4.30, verus the consensus of $4.18.
Get Real-Time Market Moving News Two-Weeks FREE http://www.streetinsider.com/premium_content.php
Related Categories
EarningsGuidance
Stocks Mentioned
+0.48Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
